CAR T-Cell Therapy Makes its Mark in CLL
David L. Porter, MD, discusses CAR T-cell therapy in chronic lymphocytic leukemia and looks towards improvements and unmet needs that remain.
Source: onclive.com
Stay updated with breaking news from Cellular Therapy Symposium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
David L. Porter, MD, discusses CAR T-cell therapy in chronic lymphocytic leukemia and looks towards improvements and unmet needs that remain.
Carrie L. Kitko, MD, discusses the current standing of cellular therapies in adult and pediatric ALL and looks toward future developments.
Lineage Cell Therapeutics, Inc. , a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M. Culley, Lineage’s Chief... | April 18, 2023